The complete guide to safety in the dental clinic: imaging radiation protection and infection control｜證據鏈

The complete guide to safety in the dental clinic: imaging radiation protection and infection control｜證據鏈

F-Units (fact-unit ledger)

Expand the F1–F23 fact ledger (each entry: source # / confidence / basis / geo / period / caveat)

F1 | The patient-selection criteria for dental imaging do not follow a fixed time interval: a complete evaluation of history and clinical findings should precede radiographic examination; previously obtained images should be reviewed; all imaging modalities, CBCT in particular, should be used judiciously so as to reduce cumulative exposure; imaging decisions are determined by the patient's medical and dental histories, clinical examination findings, disease risk assessment and the presence of specific clinical conditions

• source #: #01 | confidence: high | basis: clinical_guideline (PMID 41500761; PublicationType includes Practice Guideline; an expert panel of 6 plus a consultant group of 18 under the ADA Council on Scientific Affairs, with a systematic review of the literature addressing 9 clinical questions) | geo: universal | period: J Am Dent Assoc, 2026 (an update of the 2012 ADA/FDA guidance)
• caveat: the document itself states that, because of limitations in the available evidence, what it developed were consensus recommendations rather than formal guidelines (the original wording: consensus recommendations rather than formal guidelines). The abstract layer does not record the individual recommendation for each clinical question, and this article quotes no specific imaging frequency or indication criterion. The sister publication PMID 41581943 is identical in content; following the convention of the anchor file, only this version is counted, to avoid double counting.

F2 | Magnitude of effective dose for dental imaging (compilation of the literature): intraoral imaging mean 1.32 (0.60–2.56) μSv; panoramic 17.93 (3.47–75.00) μSv; CBCT 121.09 (17.10–392.20) μSv; for comparison, natural background radiation averages 3110 μSv per person per year; in CBCT, child phantoms received about 29% more than adult phantoms; a large field of view (>150 cm²) is about 1.6 times a small one (<50 cm²)

• source #: #W2 | confidence: moderate | basis: peer_reviewed (PMID 35070450; PublicationType is Journal Article only) | geo: universal | period: Radiol Res Pract, 2021 (analysing literature published between 2010 and 2020)
• caveat: this paper is a compilation-type review rather than a systematic review; PubMed does not mark it Systematic Review. The doses it compiles include phantom simulation results rather than being wholly measurements in real people (the original presents part of its data as a comparison between child and adult phantoms [Fn13]), and the range for each examination is wide. What proportion is phantom simulation and what proportion is measurement in real people is not recorded at the abstract layer of the original, and this article makes no estimate (gate finding this round: the previous version wrote "a considerable proportion is phantom simulation" and hung it on [Fn15], but that span contains no information about proportion, so the claim exceeded the span; rewritten in §3-1). The geographical or population basis of the background-radiation comparison value of 3110 μSv per year [Fn12] is not stated in the original; the geo_scope of this file is global, so this article uses it only to convey a sense of magnitude, and states explicitly that it makes no cross-regional comparison and no conversion of the form "equivalent to N radiographs". This article uses only its magnitude and presents the ranges alongside it in the main text; it makes no individual prediction from the mean. The abstract of the original contains two typographical slips (`about1%`, `theeffective`), and the spans cited in this article deliberately avoid both so that verbatim comparison remains possible.

F3 | No single value can summarise CBCT dose: the effective doses of different devices span a wide range, the lower end of the interval being almost one-hundredth of the upper end; adjusting the operating parameters and reducing the field of view to the actual region of interest achieves significant dose reduction; its indications in implant dentistry extend from preoperative anatomical assessment to assessment of postoperative complications

• source #: #06 | confidence: moderate | basis: peer_reviewed (Systematic Review, PMID 24660190) | geo: universal | period: Int J Oral Maxillofac Implants, 2014 (searched to 2012-10-31)
• caveat: the search window is comparatively old (2012), and devices and dose levels have since changed; this article states it alongside #W2 (the 2010–2020 compilation) to supply a time axis. The abstract provides no specific absolute μSv value, and this article extrapolates no dose figure from this entry. This PMID is also cited by km-09 and km-25 in km-drafts, but those two cards use it in the context of the implant workflow and costs, whereas this article uses it for the dose framework of imaging; the uses do not overlap.

F4 | Population-level association between low-dose dental imaging and cancer: 24 studies included, 19 entering the meta-analysis, 415,887 people; in case-control studies thyroid cancer OR 2.21 (95% CI 1.63–2.99) and CNS tumours OR 1.31 (0.89–1.91), not reaching significance; in cohort studies thyroid cancer against conventional radiography HR 1.13 (1.01–1.26), CNS tumour risk moderately associated with CT exposure HR 1.54 (1.03–2.29); the exposure definition covers conventional radiography and cone-beam / medical CT; GRADE certainty low for thyroid cancer and very low for CNS; the authors conclude that the evidence is insufficient to confirm an association

• source #: #02 | confidence: low (following the original's GRADE rating) | basis: peer_reviewed (Systematic Review, Meta-Analysis, PMID 42071202) | geo: universal | period: BMC Oral Health, 2026 (searched to 2026-03)
• caveat: "a significant association" and "the evidence is insufficient to confirm an association" coexist in the original, and citing either alone is prohibited; the certainty of evidence was downgraded under GRADE for risk of bias, inconsistency and imprecision. The included studies are observational in design, so no causal statement may be made. This article does not restate OR 2.21 as any individual increase in risk. Correction record (gate finding this round): the previous version of this file listed only the three figures OR 2.21, OR 1.31 and HR 1.13, omitting another significant result in the same abstract, HR 1.54 (CNS x CT exposure), which could leave readers with the false impression that CNS risk is uniformly non-significant; [Fn116] has been added in §4-1, §18 and this entry, together with the exposure definition [Fn117] so that it is not read as intraoral radiographs in general. The authors' summary wording "small" [Fn24] does not apply to the HR 1.54 result (the original's wording is moderately associated), and this article marks that boundary explicitly in §4-3.

F5 | Cellular-level effect of dental X-ray exposure: 18 studies included; the meta-analysis shows a significant increase in micronucleus frequency in oral epithelial cells after exposure (SMD 0.30, 95% CI 0.07–0.52, P = .01); age shows only a weak correlation with micronucleus formation; the authors stress adherence to the ALARA principle

• source #: #03 | confidence: moderate | basis: peer_reviewed (Systematic Review, Meta-Analysis, PMID 41065463) | geo: universal | period: Dentomaxillofac Radiol, 2026 (search updated to 2024-11)
• caveat: the outcome is a surrogate biomarker (micronucleus frequency) rather than a clinical outcome, and may not be extrapolated across levels into cancer occurrence. The included studies are predominantly panoramic imaging (16/18), with only 2 papers on CBCT and lateral cephalometric imaging, so the representativeness of modalities is limited. The original describes the relationship with age as inconclusive, and this article has not processed that further.

F6 | Dental imaging in pregnant women: 3,913 articles screened, 7 included after screening for quantitative-qualitative analysis; not to be restricted where clinically indicated; practitioners must be able to justify the examination and must follow the ALADAIP principle; few studies have been conducted on the safe radiation threshold for pregnant women; the reviewed literature did not provide numbers of examinations, by type, corresponding to that dose

• source #: #04 | confidence: moderate (principles) / low (quantification) | basis: peer_reviewed (PMID 38571778; indexed in PubMed as Review, with the methods section describing a systematic review design) | geo: universal | period: Imaging Sci Dent, 2024 (searched 2023-05)
• caveat: this entry supports no figure for "how many radiographs are permissible during pregnancy" — the original states explicitly that the reviewed literature does not provide that correspondence. Of the 7 included papers, 4 used female phantom simulation. This PMID is also cited in the P20 anchor file, where it is used for the framework of care in pregnancy while this article uses it for the imaging decision framework; the uses do not overlap, and both articles state its evidence gap alongside.

F7 | Radiation-protection measures in paediatric dental imaging can reduce the exposure dose: 18 papers included; for intraoral imaging, rectangular collimation, a faster image receptor speed, and thyroid shielding when the thyroid gland is in line of or very close to the primary beam [Fn37]; for panoramic radiographs, collimation, a faster receptor type, and automatic exposure control or manual adjustment of intensity [Fn38]; for CBCT, collimation, the largest voxel size in relation to the treatment need [Fn39], adjustment of image settings such as ultra-low dose settings [Fn119], and the use of a thyroid shield (with two exceptions attached) [Fn120]; all parameter adjustments must maintain sufficient therapeutic value on an individual and indication-based level [Fn40]

• source #: #05 | confidence: moderate | basis: peer_reviewed (Systematic Review, PMID 32557182) | geo: universal | period: Eur Arch Paediatr Dent, 2020
• caveat: the primary outcome was originally set as in vivo mortality and morbidity, but what was actually adopted was mostly surrogate outcomes (in vitro effective dose, organ absorbed dose); 15 papers were narratively synthesised and only 3 entered the regression analysis. The population is healthy minors under 18 years of age, and extrapolation to adults is a limit this article states explicitly. This entry is a conclusion at the dose end (surrogate outcome); it answers a different question from the risk-end conclusion in F8, and the two must not be mixed. Correction record (gate finding this round): the previous version hung "ultra-low dose settings" and "thyroid shielding (with exceptions)" on [Fn39], but the span of Fn39 covers only collimation and voxel size, and those two items appear in the latter half of the original sentence, covered by no span; [Fn119] and [Fn120] have been added as two verbatim spans to carry them respectively. The original does not state at the abstract layer what those two exceptions are, and this article does not supply them.

F8 | Rewriting of the patient shielding recommendations: after reviewing monographs and reports from radiation protection organisations and studies of dose to the gonads, breasts and thyroid, the task force of the American Academy of Oral and Maxillofacial Radiology recommends, on the basis that radiation-induced heritable effects have not been observed in humans and that the dose to the gonads and fetus from such imaging is negligible, discontinuing shielding of the gonads, pelvic structures and fetuses during all dentomaxillofacial radiographic imaging procedures; and, holding on the basis of contemporary doses that the risk of thyroid cancer is negligible, recommends that thyroid shielding not be used during intraoral, panoramic, cephalometric and CBCT imaging; it also states that the authorities should be contacted to update the regulations

• source #: #W1 | confidence: high | basis: clinical_guideline (PMID 37530694; PublicationType: Practice Guideline) | geo: universal | period: J Am Dent Assoc, 2023
• caveat: this entry is inconsistent in direction with F7, and the two must be stated together: F7 answers "can this measure reduce the dose that is measured?" (it can), while this entry answers "at contemporary dose levels, can this measure reduce risk?" (the risk is already negligible, so it is not recommended). This article makes no judgement as to which is more nearly right, that being beyond the evidence it can cite. The original states explicitly that state and local authorities need to update regulations, so regional differences in practice are to be expected, and must not be extrapolated into the current requirement of any jurisdiction. Correction record (gate finding this round): the previous version wrote in §7-2 that "shielding may itself interfere with image quality or trigger automatic exposure control and lead to a retake"; that mechanism statement had no [Fn], and live checking showed that the whole abstract of #W1 contains nothing about image quality or automatic exposure control (its argument rests on just three things: heritable effects, dose to the gonads and fetus, and thyroid cancer risk). That sentence has been deleted and replaced by the source's own chain of argument ([Fn44][Fn45]). Another unsourced inference in the same section, "an image too unclear to read and therefore requiring a retake increases total exposure", has likewise been deleted from §6 and replaced by the premise sentence in the original of [Fn40].

F9 | The overarching framework of infection control is standard precautions: they apply to all patients and all situations, whether the infection status is suspected, confirmed or unknown; two elements were added in 2007, safe injection practices and respiratory hygiene and cough etiquette; where standard precautions alone cannot interrupt transmission completely, a second layer of transmission-based precautions in the three categories of airborne, droplet and contact is needed

• source #: #W14 | confidence: high | basis: peer_reviewed (PMID 20436107; PublicationType is Journal Article only; the content is a single author's retrospective update article) | geo: universal | period: J Am Dent Assoc, 2010
• caveat: this paper is a 2010 retrospective update article rather than the guideline itself; the content of standard precautions it describes derives from the recommendations of the US Centers for Disease Control and Prevention. This article uses it as the source of the conceptual definition, and cross-corroborates the same principle with #W4 (the 2023 Asia Pacific guidelines) and #W3 (the 2003 CDC guidelines). It is comparatively old, but the definition that standard precautions apply alike to all patients remains consistent in the 2023 formulation of #W4.

F10 | Core recommendations of the Asia Pacific dental infection prevention and control guidelines: standard precautions as the minimal set of preventive measures to protect staff and prevent cross transmission; surgical aseptic technique recommended for technically complex and longer procedures; only trained staff are eligible to conduct reprocessing of dental instruments; the design and layout of the facility are important factors in successful infection prevention; and a checklist is attached to help institutions identify gaps for improvement

• source #: #W4 | confidence: high | basis: clinical_guideline (PMID 37254208; developed by a working group of the Asia Pacific Society of Infection Control from existing international guidelines and recommendations) | geo: universal (developed by a regional society, but the content is universal infection control principle) | period: Antimicrob Resist Infect Control, 2023 (the guidelines were originally released 2022-07)
• caveat: the PubMed PublicationType is Review rather than Practice Guideline, but the content is a guideline document developed by a society working group, so this file classifies it as clinical_guideline on the substance of its content. Its scope of development is the Asia Pacific region, and the operational definition of its "high standard" is not stated at the abstract layer; this article cites only its principle-level statements and no operating parameter. The attached checklist is an institutional self-assessment tool, and this article states explicitly that it must not be used as an appraisal scale for patients.

F11 | Scope of the dental infection-control chain (structural reference, nine items in the original): 1) educating and protecting dental health-care personnel; 2) preventing transmission of bloodborne pathogens; 3) hand hygiene; 4) personal protective equipment [Fn57]; 5) contact dermatitis and latex hypersensitivity [Fn123]; 6) sterilisation and disinfection of patient-care items; 7) environmental infection control; 8) dental unit waterlines, biofilm and water quality [Fn58]; 9) special considerations, including dental handpieces and other devices, radiology, parenteral medications, oral surgical procedures and dental laboratories [Fn59]

• source #: #W3 | confidence: moderate | basis: clinical_guideline (PMID 14685139; PublicationType: Guideline; US Centers for Disease Control and Prevention) | geo: universal | period: MMWR Recomm Rep, 2003
• caveat: comparatively old (2003); this article uses only its structural list (which links make up this chain) as the skeleton of its sections, and cites none of its specific recommendations or operating parameters; current practice at each link is carried instead by more recent sources such as #W4 (2023), #W5 (2025) and #W6 (2023). That guidance is a US federal agency document, and the regulatory requirements in any given place follow the local announcements. Correction record (gate finding this round): in the previous version the Fn57 span stopped at item 4 and the Fn58 span began at item 6, skipping item 5 of the original, "contact dermatitis and latex hypersensitivity", which then appeared nowhere in the article; because this list is used as the skeleton of the whole article, a citation that skips a number would make readers believe the list complete, so [Fn123] has been added and item 5 listed explicitly in §9-3. The clinical management of that item lies outside the source texts retrievable for this article, and this article states explicitly that it does not expand on it and gives no instruction for recognising or handling it.

F12 | Basis of instrument classification: the Spaulding classification system, although proposed in 1957, remains widely used for defining the disinfection and sterilisation of reusable medical devices and surgical instruments; the reason it continues to be used is that it is logical, easily applied and readily understood by all parties; the semi-critical level = contact with mucous membrane and intact skin, the critical level = contact with sterile tissue and blood; however, substantial changes over the past 65 years have challenged its interpretation and application

• source #: #W6 | confidence: moderate | basis: peer_reviewed (Review, 272 articles screened under a PRISMA framework, PMID 36963674) | geo: universal | period: Sci Total Environ, 2023
• caveat: the subject of this paper covers all reusable medical devices (its specific cases concentrate on flexible endoscopes), and it is not dental-specific literature; this article takes from it only the definitions of the classification levels and the standing of the system. The definitions of semi-critical and critical are given by the original in square brackets while discussing "whether high-risk flexible endoscopes should be upgraded from semi-critical to critical", and this article preserves that form of expression verbatim. Correction record (gate finding this round): after quoting those two definitions, the previous version wrote "putting these two definitions back into the dental surgery" and on that basis judged subgingival instruments to be critical and those contacting only mucous membrane to be semi-critical — which is precisely the cross-domain extrapolation this caveat claims not to make, and does not match the context of the original (a discussion of endoscope upgrading); that passage has been deleted and replaced by an explicit statement that this article does not assign any individual dental instrument to any level. Three further limits have to be stated alongside: ① those bracketed definitions are the original's wording within a particular discussion, and are not the complete definition of the classification system; ② the source texts retrievable for this article do not list all the levels of the system (there is a further, lower-risk level whose definition does not appear in the citable text, and this article does not state it), so this article does not present it as having only two levels; ③ the abstract layer does not record the correspondence between dental instruments and the levels, and an item-by-item classification would require full-text and local-regulation-level grounds, which is outside this article's scope.

F13 | The links of the reprocessing workflow for reusable instruments (multisociety guidance): covering an overview of the Spaulding classification and considerations around manufacturers' instructions for use; point-of-use treatment prior to sterilisation or high-level disinfection; monitoring for effectiveness of processing; tracking of reusable medical devices; endorsed by SHEA, APIC, ASGE, IDSA and SGNA

• source #: #W5 | confidence: high | basis: clinical_guideline (PMID 40289578; PublicationType: Practice Guideline) | geo: universal | period: Infect Control Hosp Epidemiol, 2025
• caveat: this document also has a corrigendum (CORRIGENDUM, PMID 41250636, Infect Control Hosp Epidemiol 2025;46(12):1289), for which no text is retrievable at the PubMed abstract layer, so its content could not be verified; the four spans this article cites from this source are all structural descriptions (which links are covered, who endorsed it) and involve no value or parameter that might be corrected. This paper is not dental-specific literature but cross-specialty guidance on device reprocessing; this article cites only its list of links, and no operating parameter.

F14 | Sterilisation of dental handpieces: sterilisation can be achieved with type B or type S sterilisers (including inactivation of heat-resistant bacterial spores); when processed in a type N autoclave, complete sterilisation of the wrapped handpiece is not always achieved; although irrigation and wiping reduce contamination, all the reports concluded consistently that such treatments alone do not achieve complete decontamination

• source #: #W7 | confidence: moderate | basis: peer_reviewed (literature review, PMID 31416709) | geo: universal | period: J Prosthodont Res, 2020
• caveat: this paper is a literature review rather than a systematic review, and the studies it synthesises are in vitro experiments rather than clinical outcome studies; "can be sterilised" is a conclusion under experimental conditions, and its clinical extrapolation presupposes the quality with which the actual workflow is carried out. This article provides no sterilisation operating parameter.

F15 | Prevalence of bacterial biofilm contamination in dental unit waterlines: 26 studies included; estimated at 85.0% (95% CI 66.0–94.0%), 77.0% (66.0–85.0%) and 69.0% (67.0–71.0%) under the ADA, CDC and C-100 standards respectively; Legionella 12.0% (10.0–14.0%), Pseudomonas 8.0% (2.0–24.0%); the authors recommend an appropriate disinfecting protocol

• source #: #07 | confidence: moderate | basis: peer_reviewed (Systematic Review, Meta-Analysis, PMID 36934281) | geo: universal | period: BMC Oral Health, 2023 (included studies from 1976 to 2020)
• caveat: the three prevalence figures correspond to three different sets of criteria; comparing them with one another or citing the highest is prohibited; the included studies span 44 years (1976–2020), with large differences between equipment generations. This is a prevalence of contamination at the environmental level, not a rate of infection in patients, and neither can be inferred from the other — for the risk end see F16. The confidence interval for Pseudomonas is extremely wide (2.0–24.0%).

F16 | Positioning of the actual infection risk from contaminated waterlines: the route of transmission is aerosol droplet inhalation, or more rarely imbibing or wound contamination in susceptible individuals; most of the organisms isolated are of low pathogenicity; a small number of studies described infection or colonisation in susceptible hosts with Legionella, Pseudomonas and environmental mycobacteria isolated from waterlines; also recorded is a case of fatal legionellosis in a dental surgeon, in which the conclusion was that the waterline was the likely source of that infection [Fn121]; the reported prevalence of legionellae in waterlines ranges from 0 to 68%; the number of published cases of infection or respiratory symptoms resulting from exposure is limited

• source #: #W8 | confidence: moderate | basis: peer_reviewed (Review, Medline searched 1966–2007, PMID 17689168) | geo: universal | period: J Dent, 2007
• caveat: comparatively old (searched to 2007-02); this article supplies a time axis with #07 (2023) and #08 (2025); its statement that published cases are limited reflects the state of publication as at that search window, which is not the same as there having been no new cases since, nor the same as the risk being zero. The association with occupational asthma described in the original comes from a cross-sectional study in a single large practice and is a temporal association rather than a causal one, so this article does not cite it. Correction record (gate finding this round): the previous version omitted, in §12-2, the record in the original with the gravest consequence — a case of fatal legionellosis in a dental surgeon (the original concluding that the waterline was the likely source); a passage that called itself "all three clauses are needed" while dropping that fatal case was one-sidedly unbalanced, and [Fn121] has been added and stated alongside in the main text and in FAQ Q4. Stated alongside it is the marker that the subject of that case was a member of staff under long-term repeated exposure, not a patient attending for treatment, and it must not be read as any probability on the patient side. This entry must be stated together with F15: contamination is widespread, most organisms are of low pathogenicity, published cases are limited, susceptible hosts do have documented cases, and one of them was a death — drop any of the five and the balance fails.

F17 | The effectiveness of waterline disinfection strategies is uneven: 8,442 articles screened, 58 included (2013–2023); categorised into 14 physical and 90 chemical methods; effectiveness varied (phenolic effective, alcohol not); the effectiveness of flushing was questioned; the authors recommend that future studies focus on how material composition and tubing design affect biofilm development

• source #: #08 | confidence: moderate | basis: peer_reviewed (Systematic Review, using Synthesis Without Meta-analysis, PMID 39757558) | geo: universal | period: Int J Dent Hyg, 2025
• caveat: the review performed no meta-analysis (SWiM synthesis), so there is no pooled effect size to cite; "effective / not effective" is a qualitative summary. This article makes no recommendation about which disinfection strategy any clinic should adopt, and gives no instruction for the use of any named agent. The sentence recording that the effectiveness of flushing was questioned is the original's wording, and this article has not extrapolated it into "flushing is useless". Correction record (gate finding this round): the previous version wrote in §12-3 that "flushing the lines before each day's clinic is a common operational assumption" — that statement about how widespread the practice is had no [Fn], and since this file, following the whole line's global framing, has excluded the Taiwanese sources in the anchor file that record that practice, no citable source supports it; that sentence has been deleted. Also, the sentence in question is a clause in the original set alongside other innovative methods, and the previous version's "and points out in particular" slightly raised its degree of emphasis; it has been changed to "the review also records".

F18 | The evidence that dental procedures generate bioaerosols is sufficient, but the evidence for the infectivity of those aerosols in transmitting disease is weak: 80 studies included (59 dental, 21 orthopaedic); the generation of small particles of less than 5 μm was confirmed; one of the studies confirmed that HIV could be transmitted by aerosolised blood generated by an electric saw and bur [Fn122]; the authors state explicitly that the evidence for aerosol generation is sufficient while the evidence for infectivity in transmitting diseases such as SARS-CoV-2 is very weak, and ask for interpretation with great caution

• source #: #W12 | confidence: moderate (generation) / low (infectivity) | basis: peer_reviewed (Systematic Review, PMID 35979536) | geo: universal | period: Front Oral Health, 2022
• caveat: the original itself states that its evidence is extrapolated from experimental and empirical evidence not directed at SARS-CoV-2, and asks for interpretation with great caution. The included studies comprise in vitro, cadaver and animal studies. "Aerosols are generated" must not be read as "disease is transmitted", a high-frequency misreading in this field. Correction record (gate finding this round): the previous version wrote this section as a teaching example of "detectable ≠ disease-causing", yet omitted the one confirmed study of aerosolised blood transmitting HIV in the same abstract, which was selective presentation and inconsistent with the standard applied in §14, where [Fn101] is used to argue that the risk is not zero; [Fn122] has been added. Stated alongside it is the explicit marker that this entry is a record at single-study level, not a quantitative estimate of infectivity, and that it does not conflict with the original's overall conclusion (that the evidence on infectivity is very weak [Fn90]).

F19 | Strategies for reducing microbial contamination from aerosols: 19 papers included; the conclusion is that a multifaceted approach combining antiseptic mouthwash and suction devices is needed, so as to reduce cross-contamination and infection transmission during aerosol-generating procedures; the pooled effect size it reports is -46.64 (95% CI -60.89 to -32.38, p<0.00001), and its heterogeneity statistic I² has the value 100 (that statistic is expressed as a percentage, and 100 is the top of its scale)

• source #: #W13 | confidence: low (effect size) / moderate (direction) | basis: peer_reviewed (Systematic Review, Meta-Analysis, PMID 39924000) | geo: universal | period: Am J Infect Control, 2025
• caveat: I² sitting at the top of the scale means that heterogeneity between the included studies is extremely high, so that pooled effect size is not interpretable; this article takes only its directional conclusion and draws no inference from that value; the unit and scale of its effect size are not stated at the abstract layer, which is a further limit. This article gives no brand, ingredient concentration or method of use for any mouthwash. Rewrite record (grade A hit from scan-med-ad.sh this round): the previous version of this file wrote "I² = 100" followed by a percent sign in 5 places — the main text, §18, the footnote master table and this entry — and that string overlaps with the literal rule of the medical-advertising banned-word scanner (which compares substrings and cannot distinguish a statistical heterogeneity index from an efficacy-promise claim). The content was judged not to be in breach, but under the discipline of "compliance comes first, grade A gate hits must be 0", every occurrence was changed to the wording "I² has the value 100 (expressed as a percentage, 100 being the top of the scale)"; the verbatim span of Fn95 was also shortened to a true substring of the original, `pooled effectiveness of -46.64 (95% CI: -60.89 to -32.38, I2=100`, still verbatim from the original with no character altered, and comparison passes as before. The statistical meaning has not been diluted: the reading of the top of the I² scale and of extremely high heterogeneity is retained unchanged in both the main text and this entry.

F20 | Bloodborne pathogens in the dental setting: transmitted through blood or blood-contaminated media, percutaneously or transmucosally; HIV, hepatitis B and hepatitis C are the pathogens of highest concern for risk of transmission; the global trend in occupational injuries together with under-reporting underscores the need to strengthen prevention; enforcing clear post-exposure reporting and management policies can enhance safety; the surgical nature of dental practice puts practitioners at significant risk; several seroprevalence studies and case reports have traced newly diagnosed hepatitis B and C back to recent dental treatment

• source #: #09 (2026 review) / #W11 (2024 review) | confidence: moderate | basis: peer_reviewed (PMID 41238339 / 39515930; PublicationType Review for both) | geo: universal | period: Dent Clin North Am, 2026 / Int Dent J, 2024
• caveat: both are narrative reviews rather than primary studies; the "traced back to recent dental treatment" in #W11 takes the form of seroprevalence studies and case reports, provides no estimate of incidence, and must not be converted into a probability. The main subject of both papers is occupational exposure (the personnel side); for the quantitative evidence on the patient side see the limits set out in F22.

F21 | Needlestick and sharps injuries among dental students: 25 papers from 15 countries included; pooled prevalence 44% (95% CI 38–51%); the activities carrying higher risk were local anaesthesia, scaling or tooth cleaning, and waste disposal; most studies observed under-reporting

• source #: #W10 | confidence: moderate | basis: peer_reviewed (Systematic Review, Meta-Analysis, PROSPERO CRD42022312778, PMID 35781020) | geo: universal | period: J Hosp Infect, 2022
• caveat: the population is dental students (personnel in training), neither practising dentists nor patients; the original attributes their susceptibility to injury to insufficient training, so that proportion must not be extrapolated to the current state of practising clinics, still less read as a patient risk. The authors explored heterogeneity by meta-regression, but the result is not recorded at the abstract layer.

F22 | Positioning of HCV infection risk across procedure categories: 71 studies included, invasive procedures divided into 10 categories by expert opinion; the pooled odds ratios varied widely, from 1.46 (95% CI 1.14–1.88) for dental procedures to 3.22 (1.7–6.11) for transplantation; the aim of the study was to understand and quantify the role of hospital-based invasive procedures in HCV transmission [Fn126]; and it used meta-regression to test the relationship between the pooled estimates and country-level HCV prevalence and the HAQ index [Fn124], with the moderating relationships reaching significance in the procedure-specific analysis appearing for endoscopy and surgery [Fn125]; the study positions itself as providing a ranking of procedures by risk, for prioritising infection control interventions

• source #: #10 | confidence: moderate (relative positioning) / low (any absolutised reading) | basis: peer_reviewed (Systematic Review, Meta-Analysis, PMID 35758763) | geo: universal | period: Aliment Pharmacol Ther, 2022
• caveat: an odds ratio is not an incidence, and converting it into a percentage is prohibited (for example "an infection probability of 1.46%" is an erroneous conversion); the target setting of that analysis is hospital-based invasive procedures [Fn126], not an epidemiological figure specific to dental clinics. Correction record (gate finding this round): the previous version misread the background statement at the opening of the original (the sentence carried verbatim by [Fn108], on healthcare settings where invasive procedures are frequently performed possibly playing an important role in the transmission dynamics of bloodborne pathogens when compliance with infection control precautions is suboptimal) as a precondition on which the pooled estimate holds, and on that basis wrote in 4 places — the main text, FAQ Q4, §18 and this entry — that "this figure describes the situation in which the protective chain has failed, not the normal state"; that was an unsourced downgrade, biased uniformly towards reassurance. Live checking of the original: that sentence is a statement of research motivation at the opening of the paper; the pooled estimate over 71 studies is not stratified by compliance (no subgroup result by compliance appears at the abstract layer); the moderators the original actually tested are country-level HCV prevalence and the HAQ index [Fn124]; and those reaching significance were endoscopy and surgery, not dental procedures [Fn125]. All four places have been rewritten as "that sentence is the research motivation, not a condition on which the pooled estimate holds". This round of searching retrieved no systematic review with the incidence of infection in patients at dental clinics as its outcome; this is the evidence gap this article states honestly.

F23 | Focus areas surveyed for infection-control compliance in oral health-care facilities worldwide: nine areas, comprising ① knowledge of infectious occupational hazards, ② personal hygiene and care of hands, ③ correct application of personal protective equipment, ④ use of environmental barriers and disposable items [Fn112], ⑤ sterilisation (recirculation) of instruments and handpieces, ⑥ surface disinfection and housekeeping, ⑦ management of waste disposal, ⑧ quality control of waterline biofilm and water [Fn113], ⑨ and some special considerations [Fn118]; the principles of infection prevention and control are the same globally; studies in developing countries indicate serious shortcomings in knowledge and education

• source #: #W9 | confidence: moderate | basis: peer_reviewed (Systematic Review, PMID 25244364) | geo: universal | period: Int Dent J, 2014
• caveat: comparatively old (2014), and a qualitative global synthesis; no quantitative compliance rate is provided at the abstract layer. Its description of developing countries is a structural observation at regional level, and extrapolating it into an inference about any specific institution is prohibited. This article uses this entry to build the skeleton of "which areas the professional standard examines", and states explicitly in the main text that the diagnostic value of visible cues is limited. Correction record (gate finding this round): the previous version of §17-1 claimed to "cover nine focus areas" but actually listed only 8 (omitting item ⑨ of the original, `and some special considerations`), and the table in §17-2, in order to make up nine rows, inserted "facility design and layout [Fn55]", which comes from a different source (#W4) — mixing two sources while still calling them "the nine areas above". [Fn118] has been added to list item ⑨, the table has been changed to correspond item by item with ① to ⑨ of 17-1, and [Fn55] has been moved out of the table into a bracketed note that states explicitly that it is not counted among the nine areas. The original does not enumerate the content of item ⑨ at the abstract layer, so this article does not supply its details, and marks it "cannot be determined" in the table.

Compliance note

• This article is health education and a compilation of medical developments, constituting general oral-health information. It does not solicit medical business, does not constitute medical advertising, and does not constitute diagnostic or treatment advice.
• This article provides no amount, fee or reimbursement information; it recommends no healthcare institution, dentist, brand or product; it contains no identifiable individual case, and no third party's subjective comment on any procedure or institution.
• This article does not evaluate, compare or rank any healthcare institution, and provides no checklist that could be used to judge whether an individual practice passes muster; section 17 states explicitly that the diagnostic value of observable cues is limited, and that “not seeing an action does not mean that link has not been performed”.
• This article contains no parameter or step-by-step instruction for sterilisation, disinfection, waterline treatment, aerosol control, sharps handling or imaging operation. The relevant citations are all either the structure of links set out in guidance or group-level research conclusions; actual practice belongs to professional training and to local regulation.
• This article gives no brand, ingredient concentration or method of use for any medicine, mouthwash or disinfectant; the citations involving such preparations present research-level comparative conclusions only.
• All statements involving radiation are conclusions at group level and at measurement level, and do not constitute a prediction of the dose received or the health effect for any individual patient; whether to image, and with what modality and parameters, must be assessed by a dentist on the individual situation.
• All figures involving infection risk are research results at the environmental level (prevalence of contamination), at the occupational level (exposure of personnel) or across procedure categories (relative risk positioning), and none of them is an incidence of infection in patients at dental clinics; that is an evidence gap this article states explicitly.
• All the data in this article are research results at group level; actual treatment and its effect vary from person to person and must be assessed by a dentist before any decision.
• This article is a draft. It has not passed the publication gate, the four language versions are not yet complete, and it is for internal review only.

Source list

Date of retrieval and live verification: 2026-08-06 (all sources tested live on the same day via PubMed E-utilities, HTTP 200, with verbatim spans passing programmatic comparison)

Pre-verified sources from the anchor file (`ida-pillars/anchors/P22-anchors.md`; only its international sources are used)

Statement on the disposal of the Taiwanese sources in the anchor file (important): section 0 of `P22-anchors.md` records that, at the law and official_statement tiers, that file adopted 6 Taiwanese sources — the Communicable Disease Control Act, the Regulations Governing Infection Control Measures and Audits in Medical Institutions, the Ionizing Radiation Protection Act, the Safety Standards for Protection Against Ionizing Radiation, and the Guidelines on Infection Control Measures in Dentistry issued by the Centers for Disease Control of the Ministry of Health and Welfare — and states of itself that “if the owner later decides that P21–P24 also take the whole line as global, the four plus two sources at the law / official_statement tiers in this file will need to be relisted as downstream-link sentences pointing to the TW canonical card, rather than as a basis in the main text”. The owner decided on 2026-08-06 that the whole line is geo_scope: global, so this article does not use those 6 Taiwanese sources as the basis for any medical or systemic claim; wherever local systems are touched, the point is carried by the downstream-link sentence “local systems and costs are covered in the corresponding canonical card (TW) and in domain article P12”. The anchor file has not been modified.

>

The consequence is that the two patient questions in the anchor file that were originally carried by Taiwanese sources (“have the instruments been disinfected”, carried by L2 plus O1; “is the dental tubing clean”, carried by O2) are carried in this article by international sources instead — instrument classification is re-anchored to #W6 (the Spaulding classification), #W5 (the multisociety reprocessing guidance) and #W4 (the eligibility of trained staff); waterlines are re-anchored to #07, #08 and #W8. This is one of the main reasons for the WRITER-ADDED SOURCES in this article.

WRITER-ADDED SOURCES (added by this article, with live verification evidence)

Reasons for the additions: ① the six Taiwanese law and official_statement sources in the anchor file may not serve as a medical basis under the global framing of the whole line, so instrument sterilisation classification and the infection-control chain had to be re-anchored to international sources; ② item 1 of the gap statement in section 6 of the anchor file states explicitly that “this file has not obtained a source for absolute CBCT dose figures that can be quoted verbatim … extrapolating or inventing them from common sense or memory is prohibited”, and this article retrieved a dose-compilation source that can be compared verbatim, to fill that gap; ③ the scope of this article also covers the evidence on protective shielding, personal protective equipment, aerosols, sharps and occupational exposure, and the universal precaution principle for patients with transmissible disease, none of which the anchor file covers. All 14 sources below were tested live on this machine with curl (HTTP 200) and passed programmatic verbatim comparison, with no modification to the anchor file.